 | • レポートコード：QFJ1-5739 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、女性用不妊治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非経口、経口、その他）、用途別市場規模（卵巣過剰刺激症候群、多胎妊娠、多胎児、早産、低出生体重、帝王切開危険性）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・女性用不妊治療薬の市場動向 ・企業の競争状況、市場シェア ・女性用不妊治療薬の種類別市場規模と予測2016-2027（非経口、経口、その他） ・女性用不妊治療薬の用途別市場規模と予測2016-2027（卵巣過剰刺激症候群、多胎妊娠、多胎児、早産、低出生体重、帝王切開危険性） ・女性用不妊治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・女性用不妊治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性用不妊治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性用不妊治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性用不妊治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc、Ferring BV、Merck KGaA、Novartis AG、Sanofi） ・結論 |
Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
The adverse effects and high cost of non-therapeutics will also boost the popularity of female infertility drugs. Various ART procedures, including IVF, IUI, and ICSI are available as alternatives to medications for the treatment of female infertility.
Market Analysis and Insights: Global Female Infertility Drugs Market
The global Female Infertility Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Infertility Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Infertility Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Infertility Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Infertility Drugs market.
Global Female Infertility Drugs Scope and Market Size
Female Infertility Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Infertility Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Parenteral
Oral
Others
Segment by Application
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Infertility Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Parenteral
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Female Infertility Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ovarian Hyperstimulation Syndrome
1.3.3 Multiple-gestation Pregnancies
1.3.4 Multiple-birth Infants
1.3.5 Premature Labor
1.3.6 Low Birth Weight
1.3.7 Risk of Cesarean Delivery
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Female Infertility Drugs Market Perspective (2016-2027)
2.2 Female Infertility Drugs Growth Trends by Regions
2.2.1 Female Infertility Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Infertility Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Female Infertility Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Female Infertility Drugs Industry Dynamic
2.3.1 Female Infertility Drugs Market Trends
2.3.2 Female Infertility Drugs Market Drivers
2.3.3 Female Infertility Drugs Market Challenges
2.3.4 Female Infertility Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Female Infertility Drugs Players by Revenue
3.1.1 Global Top Female Infertility Drugs Players by Revenue (2016-2021)
3.1.2 Global Female Infertility Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Infertility Drugs Revenue
3.4 Global Female Infertility Drugs Market Concentration Ratio
3.4.1 Global Female Infertility Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Infertility Drugs Revenue in 2020
3.5 Female Infertility Drugs Key Players Head office and Area Served
3.6 Key Players Female Infertility Drugs Product Solution and Service
3.7 Date of Enter into Female Infertility Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Female Infertility Drugs Breakdown Data by Type
4.1 Global Female Infertility Drugs Historic Market Size by Type (2016-2021)
4.2 Global Female Infertility Drugs Forecasted Market Size by Type (2022-2027)
5 Female Infertility Drugs Breakdown Data by Application
5.1 Global Female Infertility Drugs Historic Market Size by Application (2016-2021)
5.2 Global Female Infertility Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Female Infertility Drugs Market Size (2016-2027)
6.2 North America Female Infertility Drugs Market Size by Type
6.2.1 North America Female Infertility Drugs Market Size by Type (2016-2021)
6.2.2 North America Female Infertility Drugs Market Size by Type (2022-2027)
6.2.3 North America Female Infertility Drugs Market Size by Type (2016-2027)
6.3 North America Female Infertility Drugs Market Size by Application
6.3.1 North America Female Infertility Drugs Market Size by Application (2016-2021)
6.3.2 North America Female Infertility Drugs Market Size by Application (2022-2027)
6.3.3 North America Female Infertility Drugs Market Size by Application (2016-2027)
6.4 North America Female Infertility Drugs Market Size by Country
6.4.1 North America Female Infertility Drugs Market Size by Country (2016-2021)
6.4.2 North America Female Infertility Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Female Infertility Drugs Market Size (2016-2027)
7.2 Europe Female Infertility Drugs Market Size by Type
7.2.1 Europe Female Infertility Drugs Market Size by Type (2016-2021)
7.2.2 Europe Female Infertility Drugs Market Size by Type (2022-2027)
7.2.3 Europe Female Infertility Drugs Market Size by Type (2016-2027)
7.3 Europe Female Infertility Drugs Market Size by Application
7.3.1 Europe Female Infertility Drugs Market Size by Application (2016-2021)
7.3.2 Europe Female Infertility Drugs Market Size by Application (2022-2027)
7.3.3 Europe Female Infertility Drugs Market Size by Application (2016-2027)
7.4 Europe Female Infertility Drugs Market Size by Country
7.4.1 Europe Female Infertility Drugs Market Size by Country (2016-2021)
7.4.2 Europe Female Infertility Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Female Infertility Drugs Market Size (2016-2027)
8.2 Asia-Pacific Female Infertility Drugs Market Size by Type
8.2.1 Asia-Pacific Female Infertility Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Infertility Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Infertility Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Infertility Drugs Market Size by Application
8.3.1 Asia-Pacific Female Infertility Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Infertility Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Infertility Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Infertility Drugs Market Size by Region
8.4.1 Asia-Pacific Female Infertility Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Infertility Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Female Infertility Drugs Market Size (2016-2027)
9.2 Latin America Female Infertility Drugs Market Size by Type
9.2.1 Latin America Female Infertility Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Female Infertility Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Female Infertility Drugs Market Size by Type (2016-2027)
9.3 Latin America Female Infertility Drugs Market Size by Application
9.3.1 Latin America Female Infertility Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Female Infertility Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Female Infertility Drugs Market Size by Application (2016-2027)
9.4 Latin America Female Infertility Drugs Market Size by Country
9.4.1 Latin America Female Infertility Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Female Infertility Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Female Infertility Drugs Market Size (2016-2027)
10.2 Middle East & Africa Female Infertility Drugs Market Size by Type
10.2.1 Middle East & Africa Female Infertility Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Infertility Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Infertility Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Infertility Drugs Market Size by Application
10.3.1 Middle East & Africa Female Infertility Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Infertility Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Infertility Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Infertility Drugs Market Size by Country
10.4.1 Middle East & Africa Female Infertility Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Infertility Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Female Infertility Drugs Introduction
11.1.4 Allergan Plc Revenue in Female Infertility Drugs Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 Ferring BV
11.2.1 Ferring BV Company Details
11.2.2 Ferring BV Business Overview
11.2.3 Ferring BV Female Infertility Drugs Introduction
11.2.4 Ferring BV Revenue in Female Infertility Drugs Business (2016-2021)
11.2.5 Ferring BV Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Female Infertility Drugs Introduction
11.3.4 Merck KGaA Revenue in Female Infertility Drugs Business (2016-2021)
11.3.5 Merck KGaA Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Female Infertility Drugs Introduction
11.4.4 Novartis AG Revenue in Female Infertility Drugs Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Female Infertility Drugs Introduction
11.5.4 Sanofi Revenue in Female Infertility Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Female Infertility Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Parenteral
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Female Infertility Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Female Infertility Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Female Infertility Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Female Infertility Drugs Market Share by Regions (2016-2021)
Table 9. Global Female Infertility Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Female Infertility Drugs Market Share by Regions (2022-2027)
Table 11. Female Infertility Drugs Market Trends
Table 12. Female Infertility Drugs Market Drivers
Table 13. Female Infertility Drugs Market Challenges
Table 14. Female Infertility Drugs Market Restraints
Table 15. Global Female Infertility Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Female Infertility Drugs Market Share by Players (2016-2021)
Table 17. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Drugs as of 2020)
Table 18. Ranking of Global Top Female Infertility Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Female Infertility Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Female Infertility Drugs Product Solution and Service
Table 22. Date of Enter into Female Infertility Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Female Infertility Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Female Infertility Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Female Infertility Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Female Infertility Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Female Infertility Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Female Infertility Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Female Infertility Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Female Infertility Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Female Infertility Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Female Infertility Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Female Infertility Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Female Infertility Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Female Infertility Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Female Infertility Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Female Infertility Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Female Infertility Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Female Infertility Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Female Infertility Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Female Infertility Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Female Infertility Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Female Infertility Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Female Infertility Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Female Infertility Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Female Infertility Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Female Infertility Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Female Infertility Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Female Infertility Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Female Infertility Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Female Infertility Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Female Infertility Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Female Infertility Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Female Infertility Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Female Infertility Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Plc Company Details
Table 63. Allergan Plc Business Overview
Table 64. Allergan Plc Female Infertility Drugs Product
Table 65. Allergan Plc Revenue in Female Infertility Drugs Business (2016-2021) & (US$ Million)
Table 66. Allergan Plc Recent Development
Table 67. Ferring BV Company Details
Table 68. Ferring BV Business Overview
Table 69. Ferring BV Female Infertility Drugs Product
Table 70. Ferring BV Revenue in Female Infertility Drugs Business (2016-2021) & (US$ Million)
Table 71. Ferring BV Recent Development
Table 72. Merck KGaA Company Details
Table 73. Merck KGaA Business Overview
Table 74. Merck KGaA Female Infertility Drugs Product
Table 75. Merck KGaA Revenue in Female Infertility Drugs Business (2016-2021) & (US$ Million)
Table 76. Merck KGaA Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Female Infertility Drugs Product
Table 80. Novartis AG Revenue in Female Infertility Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Female Infertility Drugs Product
Table 85. Sanofi Revenue in Female Infertility Drugs Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Infertility Drugs Market Share by Type: 2020 VS 2027
Figure 2. Parenteral Features
Figure 3. Oral Features
Figure 4. Others Features
Figure 5. Global Female Infertility Drugs Market Share by Application: 2020 VS 2027
Figure 6. Ovarian Hyperstimulation Syndrome Case Studies
Figure 7. Multiple-gestation Pregnancies Case Studies
Figure 8. Multiple-birth Infants Case Studies
Figure 9. Premature Labor Case Studies
Figure 10. Low Birth Weight Case Studies
Figure 11. Risk of Cesarean Delivery Case Studies
Figure 12. Female Infertility Drugs Report Years Considered
Figure 13. Global Female Infertility Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Female Infertility Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Female Infertility Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Female Infertility Drugs Market Share by Regions (2022-2027)
Figure 17. Global Female Infertility Drugs Market Share by Players in 2020
Figure 18. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Female Infertility Drugs Revenue in 2020
Figure 20. Global Female Infertility Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Female Infertility Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Female Infertility Drugs Market Share by Type (2016-2027)
Figure 24. North America Female Infertility Drugs Market Share by Application (2016-2027)
Figure 25. North America Female Infertility Drugs Market Share by Country (2016-2027)
Figure 26. United States Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Female Infertility Drugs Market Share by Type (2016-2027)
Figure 30. Europe Female Infertility Drugs Market Share by Application (2016-2027)
Figure 31. Europe Female Infertility Drugs Market Share by Country (2016-2027)
Figure 32. Germany Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Female Infertility Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Female Infertility Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Female Infertility Drugs Market Share by Region (2016-2027)
Figure 42. China Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Female Infertility Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Female Infertility Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Female Infertility Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Female Infertility Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Female Infertility Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Female Infertility Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Female Infertility Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan Plc Revenue Growth Rate in Female Infertility Drugs Business (2016-2021)
Figure 62. Ferring BV Revenue Growth Rate in Female Infertility Drugs Business (2016-2021)
Figure 63. Merck KGaA Revenue Growth Rate in Female Infertility Drugs Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Female Infertility Drugs Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Female Infertility Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の女性不妊症治療薬産業調査2019-2025 Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been consi…- 世界の女性不妊症治療薬産業調査2019-2025 Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been consi…
- 世界の早産＆前期破水（PROM）検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market The global Preterm Birth and Premature Rupture of Membranes (PROM) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2…
- 世界の多発性硬化症薬物治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of …
- 世界の早産予防＆治療市場規模・現状・予測（2021年-2027年） Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for pr…